Marshaling artificial intelligence in the fight against Covid-19
The MIT-IBM Watson AI Lab is funding 10 research projects aimed at addressing the health and economic consequences of the pandemic.
The MIT-IBM Watson AI Lab is funding 10 research projects aimed at addressing the health and economic consequences of the pandemic.
Suggested design could make it easier to divide air flow for Covid-19 patients in emergencies when no other options are available.
Paper co-authored by MIT economist proposes a new way to handle medical shortages during the Covid-19 crisis.
Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.
Differently shaped RNA molecules allow HIV to express different genes from the same RNA sequence.
MIT economist Pierre Azoulay outlines a roadmap for scientific success against the virus.
New CRISPR-based research tool delivers results in an hour; researchers share protocol and kits to advance research and move toward clinical validation.
“We volunteered because we thought it would be a great opportunity to give back to the MIT community in a time of necessity,” says Nathan Han.
MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
At MIT, senior Tarun Kamath has explored neuroscience and science policy, while helping his peers find ways to reduce stress.
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
Comfortable, form-fitting garments could be used to remotely track patients’ health.
Manufacturability is key to producing a widely available, affordable vaccine.
Neurologist and researcher Diane Chan pitches in to help New England get through tough times.